Rapid preparation of 1-vinylimidazole based non-affinity polymers for the highly-selective purification of antibodies from multiple biological sources

J Chromatogr A. 2020 Nov 22:1632:461607. doi: 10.1016/j.chroma.2020.461607. Epub 2020 Oct 11.

Abstract

There is an urgent need for developing advanced purification techniques with the merits of low cost and satisfactory capacity in order to meet the challenges in the current downstream purification of monoclonal antibodies (mAbs). Herein, a simple and inexpensive nitrogen heterocycle molecule, 1-vinylimidazole (VIM), was proposed as the capture ligand of antibodies for the first time. The corresponding VIM-based non-affinity polymeric material (polyVIM) was then fabricated via a one-step polymerization for use in the highly selective purification of antibodies. Compared to the previously reported materials, this novel material exhibited many advantages without clearly sacrificing selectivity, such as a simpler and faster fabrication (within 1.5 h), comparable or even higher binding capacity (saturated static adsorption capacity > 190 mg/g polymer, dynamic binding capacity about 31.62 mg/g polymer), lower non-specific protein adsorption, and much lower cost. Notably, the polyVIM can effectively purify the antibodies from multiple biological sources with high purity (95.4% for mAbs in the cell culture medium, 93.3% for hIgG in the human serum), with an acceptable recovery (91.6% for mAbs, 77.0% for hIgG), and good reusability (> 10 times). Moreover, the target ELISA binding assay and NFAT-luc reporter gene assay demonstrated that the enriched antibodies can well maintain their binding activity and bioactivity during the whole purification process. The excellent performance of the polyVIM material may be attributed to the high recognition ability of VIM for antibodies, as well as the biocompatible and antifouling properties of the porous polymer. This study provides a promising alternative material for the purification of mAbs in downstream processes and the enrichment of hIgG in human serum.

Keywords: 1-vinylimidazole; Antibody purification; Cell culture medium; Human serum; Porous polymeric material.

MeSH terms

  • Adsorption
  • Animals
  • Antibodies, Monoclonal / isolation & purification*
  • Bevacizumab / isolation & purification
  • CHO Cells
  • Calorimetry
  • Cricetinae
  • Cricetulus
  • Humans
  • Imidazoles / chemistry*
  • Immunoglobulin G / blood
  • Ligands
  • Mice
  • Polymers / chemistry*
  • Spectroscopy, Fourier Transform Infrared

Substances

  • Antibodies, Monoclonal
  • Imidazoles
  • Immunoglobulin G
  • Ligands
  • Polymers
  • Bevacizumab
  • N-vinylimidazole